Cal-Maine Foods Reports Decline Amid Market Strength
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 12 2024
0mins
Should l Buy CALM?
Source: Business Insider
Cal-Maine Foods Inc. experienced a price drop of 5.40%, hitting a 52-week low amid a generally positive market environment, with the Nasdaq-100 up 0.43% and the S&P 500 up 0.13%.
This decline is attributed to a significant 19.4% year-over-year decrease in net sales, primarily driven by falling egg prices and reduced sales volume. Despite this, the company reported a Q2 earnings per share of $2.13, surpassing analyst expectations, indicating resilience in a challenging market. The ongoing low egg prices have significantly impacted profitability, leading to a 53.1% drop in net income.
The implications of these results suggest that while Cal-Maine is facing challenges, its strategic shift towards higher-value products and strong cash position may support future growth. The company's commitment to shareholder returns through share repurchases also reflects confidence in its long-term value.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CALM?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CALM
Wall Street analysts forecast CALM stock price to rise
3 Analyst Rating
1 Buy
2 Hold
0 Sell
Moderate Buy
Current: 76.310
Low
85.00
Averages
90.00
High
100.00
Current: 76.310
Low
85.00
Averages
90.00
High
100.00
About CALM
Cal-Maine Foods, Inc. is primarily engaged in the production, packaging, marketing and distribution of fresh shell eggs, including conventional, cage-free, organic, brown, free-range, pasture-raised and nutritionally enhanced eggs, as well as a variety of ready-to-eat egg products. The Company’s integrated operations consist of hatching chicks, growing and maintaining flocks of pullets, layers and breeders, manufacturing feed, and producing, processing, packaging, and distributing shell eggs. The Company provides specialty and conventional eggs. Specialty eggs encompass a broad range of products, such as cage-free, organic, brown, free-range, pasture-raised and nutritionally enhanced eggs. Its Farmhouse Eggs brand eggs are produced at its facilities by hens that are provided with a vegetarian diet. It markets organic, vegetarian and omega-3 eggs under its 4-Grain brand, which consists of conventional and cage-free eggs. Its Sunups and Sunny Meadow brands are sold as conventional eggs.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Cal-Maine Foods Recognized Among Fastest Growing Dividend Stocks
- Dividend Growth Potential: Cal-Maine Foods is recognized as one of the 10 fastest growing dividend stocks, indicating strong performance in dividend payments that attracts investor interest and may drive stock price appreciation.
- Price Target Increase: Goldman Sachs raised Cal-Maine's price target from $79 to $82 while maintaining a Neutral rating, reflecting market recognition of the company's financial performance, which could enhance investor confidence.
- Portfolio Transformation: CEO Sherman Miller highlighted that specialty egg sales accounted for 50.5% of total shell egg sales, a significant increase from last year, indicating successful product diversification that enhances market competitiveness.
- Improved Market Stability: Market conditions appear more stable than last year, with retail volumes rising approximately 3% year-to-date; although wholesale prices remain under pressure, overall supply improvements and inventory normalization will support the company's future profitability.
See More
Cal-Maine Foods Q3 Fiscal 2026 Earnings Call Insights
- Significant Sales Decline: Cal-Maine Foods reported net sales of $667 million for Q3 fiscal 2026, a 53% drop primarily driven by a 56.5% decrease in shell egg selling prices, although the company maintained a virtually debt-free balance sheet, demonstrating resilience in adversity.
- Portfolio Optimization: The company is focusing on increasing the proportion of high-value products, with specialty egg sales accounting for 50.5% of total shell egg sales and Prepared Foods representing 9.5% of net sales, indicating Cal-Maine's strategy to enhance profitability and market competitiveness through product diversification.
- Optimistic Future Outlook: Management expects Prepared Foods capacity to increase by over 30% in the next 18 to 24 months, with margin recovery anticipated to begin in Q4 of fiscal 2026, reflecting confidence in market demand and a commitment to long-term growth.
- Shareholder Return Actions: The company announced a variable dividend of approximately $0.36 per share in Q3 and repurchased 329,830 shares for a total of $24.3 million, showcasing its proactive stance on maintaining shareholder returns despite the challenges posed by declining sales.
See More
Cal-Maine Foods Exceeds Q3 Earnings Expectations Amid Sales Decline
- Earnings Beat: Cal-Maine Foods reported a net income of $50.5 million ($1.06 per share) for Q3 FY2026, surpassing analysts' expectations of $0.89 per share, despite a 53% year-over-year decline in net sales to $667 million, showcasing the company's resilience amid high egg prices.
- Stock Surge: Following the strong earnings report, Cal-Maine's stock rose by 5.32% on Wednesday, closing at $83.36 with a market cap of $3.8 billion, reflecting investor confidence in the company's recovery prospects.
- Dividend Announcement: The company declared a quarterly dividend of approximately $0.36 per share, payable on May 14 to shareholders of record as of April 29, enhancing investor return expectations despite overall sales decline.
- Optimistic Market Outlook: Although no specific guidance was provided, CEO Sherman Miller indicated expectations for a progressive recovery in prepared foods, with improved capacity utilization and steady demand positioning the business for more stable, higher-quality earnings in the long term.
See More
Cal-Maine Foods Q3 Earnings Beat Expectations Despite Revenue Drop
- Earnings Surprise: Cal-Maine Foods reported Q3 fiscal 2026 earnings of $1.06 per share, exceeding analyst expectations of $0.89, despite a 53% year-over-year drop in net sales to $667 million, indicating the company's resilience in challenging conditions.
- Stock Price Surge: Following the earnings report, Cal-Maine's stock rose over 5%, reflecting investor confidence in the company's profitability and suggesting a positive market sentiment regarding its future performance.
- Dividend Declaration: The company announced a quarterly dividend of approximately $0.36 per share, to be paid on May 14 to shareholders of record as of April 29, demonstrating its commitment to returning value to shareholders even amid declining profitability.
- Market Outlook: CEO Sherman Miller indicated expectations for a gradual recovery in prepared foods sales as capacity comes online and demand stabilizes, suggesting that the company is positioned for more stable and higher-quality earnings in the long term, despite ongoing market challenges.
See More
Cal-Maine Foods Reports Significant Q3 Earnings Volatility
- Specialty Egg Sales Surge: Cal-Maine Foods reported that specialty egg sales accounted for 50.5% of total shell egg sales in Q3 2026, up from 24.4% last year, indicating enhanced competitiveness in the premium market and expected future revenue growth.
- Prepared Foods Sales Spike: Prepared foods contributed 9.5% to net sales, a significant increase from 0.8% last year, demonstrating the company's success in diversifying its product lines, which will help improve overall profitability moving forward.
- Strong Financial Position: The company maintains a robust balance sheet with cash and temporary cash investments of $1.152 billion and is virtually debt-free, providing ample funding for future expansion and investment opportunities.
- Net Sales Decline: Despite strong performance in specialty eggs and prepared foods, Q3 2026 net sales were $667 million, a 53% decrease year-over-year, primarily due to a 72.1% drop in conventional egg sales, posing significant challenges to the company's overall financial health.
See More
Eli Lilly Gains FDA Approval, Shares Rise
- FDA Drug Approval: Eli Lilly's once-daily GLP-1 pill Foundayo received FDA approval, leading to a 4% rise in shares, which will enhance the company's competitive edge in the obesity treatment market and drive future sales growth.
- Cybersecurity Incident Impact: Hasbro's shares fell over 4% due to a cybersecurity incident involving unauthorized network access, with the company investigating the full impact and implementing protective measures, potentially increasing operational costs in the short term.
- Tobacco Product Delay: Philip Morris International's shares dropped more than 5% after the FDA delayed authorization for nicotine pouch sales, which may hinder the company's future market expansion plans, particularly among new user demographics.
- Semiconductor Buyback Plan: Intel announced a $14.2 billion buyback of a 49% stake in its Ireland Fab 34 joint venture, resulting in a 9% increase in shares, with funding sourced from cash on hand and approximately $6.5 billion in new debt, expected to strengthen its position in the global semiconductor market.
See More
Cal-Maine Foods Recognized Among Fastest Growing Dividend Stocks
- Dividend Growth Potential: Cal-Maine Foods is recognized as one of the 10 fastest growing dividend stocks, indicating strong performance in dividend payments that attracts investor interest and may drive stock price appreciation.
- Price Target Increase: Goldman Sachs raised Cal-Maine's price target from $79 to $82 while maintaining a Neutral rating, reflecting market recognition of the company's financial performance, which could enhance investor confidence.
- Portfolio Transformation: CEO Sherman Miller highlighted that specialty egg sales accounted for 50.5% of total shell egg sales, a significant increase from last year, indicating successful product diversification that enhances market competitiveness.
- Improved Market Stability: Market conditions appear more stable than last year, with retail volumes rising approximately 3% year-to-date; although wholesale prices remain under pressure, overall supply improvements and inventory normalization will support the company's future profitability.
See More
Cal-Maine Foods Q3 Fiscal 2026 Earnings Call Insights
- Significant Sales Decline: Cal-Maine Foods reported net sales of $667 million for Q3 fiscal 2026, a 53% drop primarily driven by a 56.5% decrease in shell egg selling prices, although the company maintained a virtually debt-free balance sheet, demonstrating resilience in adversity.
- Portfolio Optimization: The company is focusing on increasing the proportion of high-value products, with specialty egg sales accounting for 50.5% of total shell egg sales and Prepared Foods representing 9.5% of net sales, indicating Cal-Maine's strategy to enhance profitability and market competitiveness through product diversification.
- Optimistic Future Outlook: Management expects Prepared Foods capacity to increase by over 30% in the next 18 to 24 months, with margin recovery anticipated to begin in Q4 of fiscal 2026, reflecting confidence in market demand and a commitment to long-term growth.
- Shareholder Return Actions: The company announced a variable dividend of approximately $0.36 per share in Q3 and repurchased 329,830 shares for a total of $24.3 million, showcasing its proactive stance on maintaining shareholder returns despite the challenges posed by declining sales.
See More
Cal-Maine Foods Exceeds Q3 Earnings Expectations Amid Sales Decline
- Earnings Beat: Cal-Maine Foods reported a net income of $50.5 million ($1.06 per share) for Q3 FY2026, surpassing analysts' expectations of $0.89 per share, despite a 53% year-over-year decline in net sales to $667 million, showcasing the company's resilience amid high egg prices.
- Stock Surge: Following the strong earnings report, Cal-Maine's stock rose by 5.32% on Wednesday, closing at $83.36 with a market cap of $3.8 billion, reflecting investor confidence in the company's recovery prospects.
- Dividend Announcement: The company declared a quarterly dividend of approximately $0.36 per share, payable on May 14 to shareholders of record as of April 29, enhancing investor return expectations despite overall sales decline.
- Optimistic Market Outlook: Although no specific guidance was provided, CEO Sherman Miller indicated expectations for a progressive recovery in prepared foods, with improved capacity utilization and steady demand positioning the business for more stable, higher-quality earnings in the long term.
See More
Cal-Maine Foods Q3 Earnings Beat Expectations Despite Revenue Drop
- Earnings Surprise: Cal-Maine Foods reported Q3 fiscal 2026 earnings of $1.06 per share, exceeding analyst expectations of $0.89, despite a 53% year-over-year drop in net sales to $667 million, indicating the company's resilience in challenging conditions.
- Stock Price Surge: Following the earnings report, Cal-Maine's stock rose over 5%, reflecting investor confidence in the company's profitability and suggesting a positive market sentiment regarding its future performance.
- Dividend Declaration: The company announced a quarterly dividend of approximately $0.36 per share, to be paid on May 14 to shareholders of record as of April 29, demonstrating its commitment to returning value to shareholders even amid declining profitability.
- Market Outlook: CEO Sherman Miller indicated expectations for a gradual recovery in prepared foods sales as capacity comes online and demand stabilizes, suggesting that the company is positioned for more stable and higher-quality earnings in the long term, despite ongoing market challenges.
See More
Cal-Maine Foods Reports Significant Q3 Earnings Volatility
- Specialty Egg Sales Surge: Cal-Maine Foods reported that specialty egg sales accounted for 50.5% of total shell egg sales in Q3 2026, up from 24.4% last year, indicating enhanced competitiveness in the premium market and expected future revenue growth.
- Prepared Foods Sales Spike: Prepared foods contributed 9.5% to net sales, a significant increase from 0.8% last year, demonstrating the company's success in diversifying its product lines, which will help improve overall profitability moving forward.
- Strong Financial Position: The company maintains a robust balance sheet with cash and temporary cash investments of $1.152 billion and is virtually debt-free, providing ample funding for future expansion and investment opportunities.
- Net Sales Decline: Despite strong performance in specialty eggs and prepared foods, Q3 2026 net sales were $667 million, a 53% decrease year-over-year, primarily due to a 72.1% drop in conventional egg sales, posing significant challenges to the company's overall financial health.
See More
Eli Lilly Gains FDA Approval, Shares Rise
- FDA Drug Approval: Eli Lilly's once-daily GLP-1 pill Foundayo received FDA approval, leading to a 4% rise in shares, which will enhance the company's competitive edge in the obesity treatment market and drive future sales growth.
- Cybersecurity Incident Impact: Hasbro's shares fell over 4% due to a cybersecurity incident involving unauthorized network access, with the company investigating the full impact and implementing protective measures, potentially increasing operational costs in the short term.
- Tobacco Product Delay: Philip Morris International's shares dropped more than 5% after the FDA delayed authorization for nicotine pouch sales, which may hinder the company's future market expansion plans, particularly among new user demographics.
- Semiconductor Buyback Plan: Intel announced a $14.2 billion buyback of a 49% stake in its Ireland Fab 34 joint venture, resulting in a 9% increase in shares, with funding sourced from cash on hand and approximately $6.5 billion in new debt, expected to strengthen its position in the global semiconductor market.
See More
